Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs

Molecules. 2022 Mar 29;27(7):2220. doi: 10.3390/molecules27072220.

Abstract

Pentacyclic triterpenoic acids (betulinic, oleanolic, ursolic, and platanic acid) were selected and subjected to acetylation followed by the formation of amides derived from either piperazine or homopiperazine. These amides were coupled with either rhodamine B or rhodamine 101. All of these compounds were screened for their cytotoxic activity in SRB assays. As a result, the cytotoxicity of the parent acids was low but increased slightly upon their acetylation while a significant increase in cytotoxicity was observed for piperazinyl and homopiperazinyl amides. A tremendous improvement in cytotoxicity was observed; however, for the rhodamine B and rhodamine 101 conjugates, and compound 27, an ursolic acid derived homopiperazinyl amide holding a rhodamine 101 residue showed an EC50 = 0.05 µM for A2780 ovarian cancer cells while being less cytotoxic for non-malignant fibroblasts. To date, the rhodamine 101 derivatives presented here are the first examples of triterpene derivatives holding a rhodamine residue different from rhodamine B.

Keywords: betulinic acid; cytotoxicity; oleanolic acid; rhodamine 101; rhodamine B; triterpenoic acid; ursolic acid.

MeSH terms

  • Amides / chemistry
  • Amides / pharmacology
  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Female
  • Humans
  • Ovarian Neoplasms*
  • Rhodamines / chemistry
  • Structure-Activity Relationship
  • Triterpenes* / chemistry
  • Triterpenes* / pharmacology

Substances

  • Amides
  • Antineoplastic Agents
  • Rhodamines
  • Triterpenes
  • rhodamine B